21029 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4)
Methods of treatment of schizophrenia
#302Compositions and Methods for Safe Treatment of Rhinitis
#303Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue
#304Antibacterial phage, phage peptides and methods of use thereof
#305PROTEIN STABILIZED PROBIOTICS AND PERSONAL CARE PRODUCTS
#306Methods and compositions for improving growth of meat-type poultry
#307Pharmaceutical composition for treating lysosomal storage disease
#308Method of treating toxemia
#309Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy
#310Methods of treatment with elastase
#311Method for using an enzyme resistant to high pressures
#312Methods of treating Celiac disease
#313Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes
#314Treatment of traumatic-induced migraine headache
#315CONFECTION COMPOSITION
#316Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
#317Targeted enzymatic degradation of quorum-sensing peptides
#318TREATMENT OF MIGRAINE HEADACHE WITH DIFFUSION OF TOXIN IN NON-MUSCLE RELATED AREAS OF THE MOUTH
#319Treatment of migraine headache with diffusion of toxin in non-muscle related foraminal sites
#320Adeno-associated virus vector for gene transfer to nervous system cells
#321Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases
#322METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS
#323Lactocepins For Use in the Treatment of IP-10-Mediated Inflammatory Diseases
#324BMP-4 peptides and methods of use
#325BMP-7 peptides and methods of use
#326Fibrin Formulations for Wound Healing
#327Maturation of gastrointestinal tract
#328PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME
#329Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof
#330Proteases for Degrading Gluten
#331Compositions and methods for reducing the incidence of equine digestive disorders
#332METHOD OF TREATING PSYCHOLOGICAL DISORDERS
#333Lipase variants for pharmaceutical use
#334Method for treating pervasive development disorders
#335Methods for improving gut health
#336Fast acting SNARE-cleaving enzymes
#337Method for producing pancreatin pellets
#338Method for treating pervasive development disorders
#339Non-cytotoxic protein conjugates
#340Enzyme Delivery Systems and Methods of Preparation and Use
#341Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes
#342Enzyme treatment of foodstuffs for celiac sprue
#343Method for treating pervasive development disorders
#344Method for treating pervasive development disorders
#345Treatment of diseases related to hyperactivity of the complement system
#346Enzyme delivery systems and methods of preparation and use
#347Apparatus and methods for enzymatic debridement of skin lesions
#348Targeting PAX2 for the treatment of breast cancer
#349Methods and compositions for improving growth of pigs
#350TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#351TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#352TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#353Targeting PAX2 for the treatment of breast cancer
#354Targeting PAX2 for the treatment of breast cancer
#355Targeting PAX2 for the treatment of breast cancer
#356TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#357TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#358TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#359METHODS OF TREATING HEMORHEOLOGIC ABNORMALITIES IN MAMMALS
#360Clostridial neurotoxins with altered persistency
#361Methods of prolonging patency of hemodialysis access
#362Methods and compositions for the treatment of symptoms of neurological and mental health disorders
#363Formulation for oral administration of proteins
#364MYCOTOXIN-REDUCING COMPOSITION
#365GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR EXTENDED RELEASE OF POLYPEPTIDES
#366CONTROLLED RELEASE ENZYMATIC COMPOSITION AND METHODS OF USE
#367METHODS OF TREATING HIV AND INFLUENZA INFECTIONS USING ASPERGILLUS ORYZAE PROTEASE
#368Polysaccharide-protein conjugates reversibly coupled via imine bonds
#369Proteinases destroy cancer tumor's solid structure and kill cancer cells locally
#370Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases
#371Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
#372Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease
#373Pancreatine pellets and method of producing same
#374Antimicrobial Agents for the Treatment of Campylobacter Species in the Crop of a Bird
#375Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci
#376COMPOSITIONS AND METHODS COMPRISING BASIC AMINO ACID PEPTIDES AND PROTEASES
#377ENZYMES FOR TREATMENT OF GINGIVITIS
#378Enzyme delivery systems and methods of preparation and use
#379Compositions and methods for preventing cardiac arrhythmia
#380COMBINATION ENZYME FOR CYSTIC FIBROSIS
#381REDUCTION OF ADIPOSE TISSUE
#382Targeting PAX2 for the treatment of breast cancer
#383System for obfuscating identity
#384COMPOSITIONS AND METHODS FOR TREATING PANCREATIC INSUFFICIENCY
#385System for obfuscating identity
#386Triple acting antimicrobials that are refractory to resistance development
#387Organic Compounds
#388NOVEL USE OF ANTIDEPRESSANT COMPOUNDS AND RELATED COMPOSITIONS
#389Degradation of prion protein and reduced prion infectivity by earthworm homogenates
#390Lipase variants for pharmaceutical use
#391Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
#392Horse feed and treatment methods
#393METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#394Methods and compositions for the treatment of symptoms of Williams Syndrome
#395Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases
#396Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy
#397Method of Preparing a Hydrogel
#398Antioxidant polymer nanocarriers for use in preventing oxidative injury
#399Horse feed and methods of treating horses
#400Compositions and use thereof for treating symptoms of preeclampsia
#401Method for detecting infectious parvovirus in pharmaceutical preparations
#402INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS
#403Method for identifying autistic individuals amenable to digestive enzyme therapy
#404DIETARY ANTI-BACTERIAL COMPOSITIONS
#405Intestinal absorptive anti-tumor agent
#406Method for treating pervasive development disorders
#407Prion deactivating composition and methods of using same
#408Methods for enlarging the lumen of an obstructed biological conduit
#409Methods for enlarging the diameter of a biological conduit in a human subject
#410Pharmaceutical preparation with RNA as hemostasis cofactor
#411NUTRACEUTICAL COMPOSITIONS AND METHODS WITH BIOLOGICALLY ACTIVE INGREDIENTS
#412Cosmeceutical Compositions and Methods with Biologically Active Ingredients
#413Compositions Useful for Recovering Original Trophism and Pigmentation, and for Stimulating Growth of the Integumentary Apparatus, Uses and Products Thereof
#414METHODS AND RELATED SYSTEMS AND FORMULATIONS TO NORMALIZE AND IMPROVE HUMAN BODY CHEMISTRY AND HEALING ABILITY
#415Methods of treating pervasive development disorders
#416Compositions for treatment of gastro-esophageal reflux disorders
#417PROTEASE COMPOSITION AND METHOD FOR TREATING A DIGESTIVE DISORDER
#418ENZYME COMPOSITION FOR IMPROVING FOOD DIGESTION
#419Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
#420COMBINATION ENZYME FOR CYSTIC FIBROSIS
#421Method of screening for agents that modulate Tysnd1 level or activity in a cell.
#422Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
#423System for obfuscating identity
#424METHODS FOR TREATMENT OF INFLAMMATORY DISEASE AND CHLAMYDIA INFECTIOUS DISEASE
#425Method of treatment using protease
#426Enzyme treatment of foodstuffs for celiac sprue
#427System for obfuscating identity
#428System for obfuscating identity
#429DIETARY SUPPLEMENTS CONTAINING NATURAL INGREDIENTS
#430Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
#431Nutrient absorption enhancing compositions and methods
#432Method for Treating Oncological, Virulent and Somatic Diseases, Method for Controlling Treatment Efficiency, Pharmaceutical Agents and Composition for Carrying Out Said Treatment
#433Pharmaceutical preparation with RNA as hemostasis cofactor
#434Protease compositions for the treatment of damaged tissue
#435Delayed release pancreatin compositions
#436Process for the manufacture and use of pancreatin micropellet cores
#437PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS
#438Apparatus and methods for enzymatic debridement of skin lesions
#439Cross-beta structures on microbial organisms
#440Method for treating oncological diseases
#441Method for reducing obstructive hydrocephalus
#442Combination enzyme for cystic fibrosis
#443Methods for treating pervasive development disorders
#444Methods for treating pervasive development disorders
#445Reduction of adipose tissue
#446Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease
#447Use of proteases for decomposing allergens
#448Antioxidant polymer nanocarriers for use in preventing oxidative injury
#449Compositions and methods for treating pancreatic insufficiency
#450Dietary supplement for treating and preventing gastrointestinal disorders
#451Method for treating cardiac muscle disorders
#452Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
#453Compositions and methods for tissue repair
#454Pharmaceutical compositions of lipase-containing products, in particular of pancreation
#455Palliative treatment for gluten intolerance
#456Dietary supplements containing natural ingredients
#457Pharmaceutical preparation with RNA as hemostasis cofactor
#458Glycoprotein matrix compositions and methods related thereto
#459Methods and compositions for prevention of angioproliferation
#460Compositions and methods for treating pancreatic enzyme deficiencies in mammals
#461Feed and method for the treatment of Coprophagia